VF
ONSIZ

Virtu Financial’s Oncobiologics, Inc. Series B Warrant ONSIZ Stock Holding History

Virtu Financial’s Portfolio ONSIZ Stock Details ONSIZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,980
Closed -$1K – 3360
2017
Q3 		$1K Buy
+11,980
New +$788 ﹤0.01% 2463

Other funds holding ONSIZ

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Virtu Financial's ONSIZ Position: Q4 2017 in Review

Virtu Financial sold out of Oncobiologics, Inc. Series B Warrant (ONSIZ) in Q4 2017, closing a stake of 11,980 shares — an estimated $1K sold.

Virtu Financial first reported a position in ONSIZ in Q3 2017 and held it in 1 quarter. The position peaked at $1K in Q3 2017. 8 funds tracked by Wall St. Rank hold ONSIZ as of Q4 2017.

  • Virtu Financial reported no remaining Oncobiologics, Inc. Series B Warrant position as of Q4 2017 after selling out during the quarter.
  • Virtu Financial sold 11,980 Oncobiologics, Inc. Series B Warrant shares in Q4 2017, an estimated $1K.
  • Virtu Financial first reported a position in Oncobiologics, Inc. Series B Warrant in Q3 2017 and held it in 1 quarter.
  • Virtu Financial's Oncobiologics, Inc. Series B Warrant position peaked at $1K in Q3 2017.
  • 8 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series B Warrant as of Q4 2017.

Based on Virtu Financial's 13F filing for Q4 2017, filed 9 Feb 2018.